Penumbra Inc
(STU:0P8)
€
166.25
-0.75 (-0.45%)
Market Cap: 6.53 Bil
Enterprise Value: 6.43 Bil
PE Ratio: 551.91
PB Ratio: 6.28
GF Score: 86/100 Penumbra Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2022 / 09:10AM GMT
Release Date Price:
€185
(-0.54%)
Michael Anthony Sarcone
Jefferies LLC, Research Division - Equity Analyst
Good morning, and welcome to day 1 of the Jefferies 2022 London Healthcare Conference. My name is Michael Sarcone. I'm an analyst on the U.S. Medical Supplies and Devices team. And with us today, we're happy to have Penumbra, and we have Adam Elsesser, Co-Founder, Chairman and CEO. So Adam, thanks for joining us today.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
My pleasure.
Questions & Answers
Michael Anthony Sarcone
Jefferies LLC, Research Division - Equity Analyst
Great. So just to kick it off. It's a really exciting time for Penumbra. You've talked about 2023 as being one of the most exciting years in the company's history. I was hoping you could just take some time and kick off why that is and just give us an overview.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. No, thank you. Again, thank you for having us. 2023 is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot